← Al het nieuws

Apply for the Merck Advance Biotech Grant Program

Your promising molecule requires resources and support to realize its potential. The Merck Advance Biotech Grant Program is open to European* biotech companies, to help you accelerate to the clinic faster. Apply before March 12, 2021 for a chance to win bioprocessing**/Actives and Formulation products and consultation.

The Winner will receive €255,000 to be used for the purchase of the following:

  • 160,000€ in bioprocess technologies
  • 40,000€ in bioprocess consulting services
  • 40,000€ in Actives and Formulations catalogue portfolio for biomolecule formulation
  • 15,000€ in a full subscription to Emprove® Suite for a one-year period

*Austria, Belgium, Denmark, France, Finland, Germany, Ireland, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, and United Kingdom. – see official rules for eligibility.

**Excludes BioReliance® Services

Flyer: https://www.hollandbio.nl/wp-content/uploads/2021/03/SAS2192-End-of-Year-Grant-Program-Flyer_V7.pdf